Shanghai, China

Songsong Tang

This inventor holds 2 USPTO granted patents and 9 published patent applications and 1 EPO patent. Top assignees: Shanghai United Imaging Healthcare Co., Ltd., Shanghai United Imaging Healthcare Ltd.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Songsong Tang. Retrieved from https://idiyas.com/inventor/songsong-tang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Songsong TANG - Innovative Inventor from Shanghai

Introduction: Songsong TANG is a renowned inventor hailing from Shanghai, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Songsong TANG holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating a more efficient and eco-friendly world.

Career Highlights: With a career spanning over two decades, Songsong TANG has worked with leading tech companies and research institutions, spearheading projects that have revolutionized various industries.

Collaborations: Songsong TANG has collaborated with top universities and multinational corporations on cutting-edge research initiatives, demonstrating his ability to work across disciplines and sectors to drive innovation forward.

Conclusion: Songsong TANG's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the global tech community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…